• No results found

Cover Page The following handle

N/A
N/A
Protected

Academic year: 2021

Share "Cover Page The following handle"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Cover Page

The following handle holds various files of this Leiden University dissertation:

http://hdl.handle.net/1887/58873 Author: Chen, X.

Title: Human pharmacology of current and novel gaba(a)-ergic treatments for anxiety

Issue Date: 2017-10-17

(2)

human pharmacology of current and novel gaba(a)-ergic treatments for anxiety 168

list of publications

Chen X, Broeyer F, de Kam M, Baas J, Cohen A, van Gerven J. Pharmacodynamic response profiles of anxiolytic and sedative drugs. Br J Clin Pharmacol. 2017 May;

83(5):1028-1038. doi: 10.1111/bcp.13204. Epub 2017 Mar 17.

Te Beek ET, Chen X, Jacobs GE, Nahon KJ, de Kam ML, Lappalainen J, Cross AJ, van Gerven JM, Hay JL. The effects of the nonselective benzodiazepine loraze- pam and the α2 /α3 subunit-selective gabaA receptor modulators azd7325 and azd6280 on plasma prolactin levels. Clin Pharmacol Drug Dev. 2015 Mar;4(2):149- 54. doi: 10.1002/cpdd.134.

Chen X, Zuiker RG, Østerberg O, Mirza NR, Muglia P, de Kam M, Klaassen ES, van Gerven JM. ns11821, a partial subtype-selective gabaA agonist, elicits selec- tive effects on the central nervous system in randomized controlled trial with healthy subjects. J Psychopharmacol. 2016 Mar; 30(3): 253-62. doi: 10.1177 / 0269881115620435.

Chen X, Jacobs G, de Kam ML, Jaeger J, Lappalainen J, Maruff P, Smith MA, Cross AJ, Cohen A, van Gerven J. azd6280, a novel partial γ-aminobutyric acid A receptor modulator, demonstrates a pharmacodynamically selective effect profile in healthy male volunteers. J Clin Psychopharmacol. 2015 Feb;35(1):22-33. doi: 10.1097/

JCP.0000000000000251.

Chen X, Jacobs G, de Kam M, Jaeger J, Lappalainen J, Maruff P, Smith MA, Cross AJ, Cohen A, van Gerven J. The central nervous system effects of the partial gaba- aα2,3 -selective receptor modulator azd7325 in comparison with lorazepam in healthy males. Br J Clin Pharmacol. 2014 Dec;78(6):1298-314. doi: 10.1111/bcp.12413.

Chen X, de Haas S, de Kam M, van Gerven J. An Overview of the cns-Pharmacody- namic Profiles of Nonselective and Selective gaba Agonists. Adv Pharmacol Sci.

2012;2012:134523. doi: 10.1155/2012/134523. Epub 2012 Jan 29.

Baas JM, Mol N, Kenemans JL, Prinssen EP, Niklson I, Chen X, Broeyer F, van Gerven J.

Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine. Psycho- pharma cology (Berl). 2009 Jul; 205(1): 73-84.

304_Connie_Proefschrift_19.indd 168 12-09-17 17:55

Referenties

GERELATEERDE DOCUMENTEN

Title: Impact of low-carbon electricity development on carbon emissions in China Issue Date:

Glycerol tri[ 3 H]oleate ([ 3 H]TO) and [ 14 C]cholesteryl oleate ([ 14 C]CO) labeled triglyceride-rich lipoprotein (TRL)- mimicking particles of different size (45, 80 and 150

We next sought to elucidate the mechanism underlying the increased hepatic uptake of cholesterol-enriched remnant particles after statin treatment in addition to β3-AR agonism.

After 9 weeks of treatment, liver samples were collected and RT-qPCR was used to measure mRNA expression of genes involved in (A) the classical bile acid (BA) synthesis pathway,

In the present study, we provide evidence that short-term cooling, the most important physiological activator of BAT, increases serum concentration of TG and apoB due to the an

Hematopoietic IL-37 expression does not affect metabolic parameters Human IL-37 was selectively expressed in hematopoietic cells, including macrophages, of atherosclerosis-prone

In summary, our results do not support a fundamental role for Dectin-2 in inflammation or atherosclerotic lesion development, while they show that deletion of hematopoietic

Hematopoietic deletion of the downstream master regulator of the CLR family CARD9 also does not influence atherosclerotic lesion size, but does appear to moderately impact